ALDX
Price
$4.80
Change
+$0.28 (+6.19%)
Updated
Jul 10 closing price
Capitalization
270.73M
28 days until earnings call
ORMP
Price
$2.12
Change
-$0.05 (-2.30%)
Updated
Jul 10 closing price
Capitalization
88.65M
33 days until earnings call
Interact to see
Advertisement

ALDX vs ORMP

Header iconALDX vs ORMP Comparison
Open Charts ALDX vs ORMPBanner chart's image
Aldeyra Therapeutics
Price$4.80
Change+$0.28 (+6.19%)
Volume$1.41M
Capitalization270.73M
Oramed Pharmaceuticals
Price$2.12
Change-$0.05 (-2.30%)
Volume$26.95K
Capitalization88.65M
ALDX vs ORMP Comparison Chart in %
Loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALDX vs. ORMP commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a StrongBuy and ORMP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (ALDX: $4.52 vs. ORMP: $2.12)
Brand notoriety: ALDX and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 160% vs. ORMP: 37%
Market capitalization -- ALDX: $270.73M vs. ORMP: $88.65M
ALDX [@Biotechnology] is valued at $270.73M. ORMP’s [@Biotechnology] market capitalization is $88.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • ALDX’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ALDX is a better buy in the long-term than ORMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 5 TA indicator(s) are bullish while ORMP’s TA Score has 2 bullish TA indicator(s).

  • ALDX’s TA Score: 5 bullish, 4 bearish.
  • ORMP’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, ALDX is a better buy in the short-term than ORMP.

Price Growth

ALDX (@Biotechnology) experienced а +13.00% price change this week, while ORMP (@Biotechnology) price change was -2.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.89%. For the same industry, the average monthly price growth was +16.25%, and the average quarterly price growth was +20.89%.

Reported Earning Dates

ALDX is expected to report earnings on Nov 13, 2025.

ORMP is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+9.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALDX($271M) has a higher market cap than ORMP($88.6M). ALDX YTD gains are higher at: -3.808 vs. ORMP (-12.397). ORMP has higher annual earnings (EBITDA): -21.53M vs. ALDX (-55.54M). ORMP has more cash in the bank: 131M vs. ALDX (90.1M). ORMP has less debt than ALDX: ORMP (301K) vs ALDX (15.6M). ORMP has higher revenues than ALDX: ORMP (2M) vs ALDX (0).
ALDXORMPALDX / ORMP
Capitalization271M88.6M306%
EBITDA-55.54M-21.53M258%
Gain YTD-3.808-12.39731%
P/E RatioN/A20.91-
Revenue02M-
Total Cash90.1M131M69%
Total Debt15.6M301K5,183%
FUNDAMENTALS RATINGS
ALDX vs ORMP: Fundamental Ratings
ALDX
ORMP
OUTLOOK RATING
1..100
2861
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
57
Fair valued
PROFIT vs RISK RATING
1..100
96100
SMR RATING
1..100
9793
PRICE GROWTH RATING
1..100
3562
P/E GROWTH RATING
1..100
10052
SEASONALITY SCORE
1..100
4485

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALDX's Valuation (46) in the Biotechnology industry is in the same range as ORMP (57) in the Pharmaceuticals Other industry. This means that ALDX’s stock grew similarly to ORMP’s over the last 12 months.

ALDX's Profit vs Risk Rating (96) in the Biotechnology industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that ALDX’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's SMR Rating (93) in the Pharmaceuticals Other industry is in the same range as ALDX (97) in the Biotechnology industry. This means that ORMP’s stock grew similarly to ALDX’s over the last 12 months.

ALDX's Price Growth Rating (35) in the Biotechnology industry is in the same range as ORMP (62) in the Pharmaceuticals Other industry. This means that ALDX’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's P/E Growth Rating (52) in the Pharmaceuticals Other industry is somewhat better than the same rating for ALDX (100) in the Biotechnology industry. This means that ORMP’s stock grew somewhat faster than ALDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALDXORMP
RSI
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 1 day ago
79%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 28 days ago
79%
Bearish Trend 14 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WLDBF1.520.05
+3.13%
WILDBRAIN LTD.
MXROF0.03N/A
+2.42%
MAX Resource Corp.
NHYDY6.100.11
+1.84%
Norsk Hydro ASA
SHZNY41.00N/A
N/A
Shenzhen Expressway Corporation Limited
CSLUF10.92N/A
N/A
CSLM Acquisition Corp.

ALDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with CANF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then CANF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
+6.19%
CANF - ALDX
46%
Loosely correlated
+0.49%
CGON - ALDX
40%
Loosely correlated
+0.26%
CMVLF - ALDX
39%
Loosely correlated
N/A
CLLS - ALDX
39%
Loosely correlated
+1.54%
PLRX - ALDX
38%
Loosely correlated
+2.94%
More